Previous close | 96.00 |
Open | 96.00 |
Bid | 94.20 |
Ask | 102.20 |
Strike | 100.00 |
Expiry date | 2024-09-20 |
Day's range | 96.00 - 96.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
BAX vs. PODD: Which Stock Is the Better Value Option?
Key Insights Insulet's estimated fair value is US$206 based on 2 Stage Free Cash Flow to Equity Insulet's US$230 share...
Insulet Corp, headquartered in Acton, Massachusetts, is a medical device company primarily engaged in the development, manufacture, and sale of insulin infusion systems for people with insulin-dependent diabetes. Over the past year, Timothy Scannell has sold a total of 15,300 shares of Insulet Corp and has not made any purchases of the stock. Shares of Insulet Corp were trading at $225.84 on the day of the sale.